These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2357866)

  • 1. Differences in stereoselective disposition of propranolol do not explain sensitivity differences between white and Chinese subjects: correlation between the clearance of (-)- and (+)-propranolol.
    Zhou HH; Wood AJ
    Clin Pharmacol Ther; 1990 Jun; 47(6):719-23. PubMed ID: 2357866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial differences in drug response. Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites.
    Zhou HH; Koshakji RP; Silberstein DJ; Wilkinson GR; Wood AJ
    N Engl J Med; 1989 Mar; 320(9):565-70. PubMed ID: 2536896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of effect of ageing on the stereochemical disposition of propranolol.
    Zhou HH; Whelan E; Wood AJ
    Br J Clin Pharmacol; 1992 Jan; 33(1):121-3. PubMed ID: 1540484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial differences in propranolol pharmacokinetics.
    Johnson JA; Burlew BS
    Clin Pharmacol Ther; 1992 May; 51(5):495-500. PubMed ID: 1587062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of differences in plasma binding of propranolol to ethnic differences in sensitivity. Comparison between Chinese and Caucasians.
    Zhou HH; Shay SD; Wood AJ
    Chin Med J (Engl); 1993 Dec; 106(12):898-902. PubMed ID: 8143506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of age on the protein binding and disposition of propranolol stereoisomers.
    Lalonde RL; Tenero DM; Burlew BS; Herring VL; Bottorff MB
    Clin Pharmacol Ther; 1990 Apr; 47(4):447-55. PubMed ID: 2328552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective clearance and distribution of intravenous propranolol.
    Olanoff LS; Walle T; Walle UK; Cowart TD; Gaffney TE
    Clin Pharmacol Ther; 1984 Jun; 35(6):755-61. PubMed ID: 6734027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective hydrolysis of O-isovaleryl propranolol and its influence on the clearance of propranolol after oral administration.
    Shameem M; Imai T; Yoshigae Y; Sparreboom A; Otagiri M
    J Pharm Sci; 1994 Dec; 83(12):1754-7. PubMed ID: 7891307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age and gender influence the stereoselective pharmacokinetics of propranolol.
    Gilmore DA; Gal J; Gerber JG; Nies AS
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1181-6. PubMed ID: 1602383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased suppression of exercise-induced increase in renin by propranolol in Chinese subjects.
    Zhou HH; Wood AJ
    Clin Pharmacol Ther; 1991 Aug; 50(2):150-6. PubMed ID: 1868676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steady state relative bioavailability and pharmacokinetics of oral propranolol in black and white North Americans.
    Sharoky M; Perkal M; Turner R; Lesko LJ
    Biopharm Drug Dispos; 1988; 9(5):447-56. PubMed ID: 3224162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective urinary excretion of S-(-)- and R-(+)-propranolol glucuronide following oral administration of RS-propranolol in Chinese Han subjects.
    Luan LJ; Shao Q; Ma JY; Zeng S
    World J Gastroenterol; 2005 Mar; 11(12):1822-4. PubMed ID: 15793873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in pharmacokinetics of oral propranolol in healthy Chinese volunteers.
    Xie HG; Chen X
    Zhongguo Yao Li Xue Bao; 1995 Sep; 16(5):468-70. PubMed ID: 8701771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereoselective oral bioavailability of (+/-)-propranolol in the dog. A GC-MS study using a stable isotope technique.
    Walle T; Walle UK
    Res Commun Chem Pathol Pharmacol; 1979 Mar; 23(3):453-64. PubMed ID: 461970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective differences in propranolol disposition in female Sprague-Dawley and Dark Agouti rats.
    Guttendorf RJ; Kostenbauder HB; Wedlund PJ
    Drug Metab Dispos; 1991; 19(1):251-6. PubMed ID: 1673410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age and propranolol stereoselective disposition in humans.
    Colangelo PM; Blouin RA; Steinmetz JE; McNamara PJ; DeMaria AN; Wedlund PJ
    Clin Pharmacol Ther; 1992 May; 51(5):489-94. PubMed ID: 1587061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective disposition of propranolol in rabbits. Role of presystemic organs and dose.
    Marier JF; Pichette V; du Souich P
    Drug Metab Dispos; 1998 Feb; 26(2):164-9. PubMed ID: 9456303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct enantioselective determination of (R)- and (S)-propranolol in human plasma. Application to pharmacokinetic studies.
    Egginger G; Lindner W; Brunner G; Stoschitzky K
    J Pharm Biomed Anal; 1994 Dec; 12(12):1537-45. PubMed ID: 7696378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Halothane inhibition of propranolol metabolism is stereoselective.
    Whelan E; Wood AJ; Koshakji R; Shay S; Wood M
    Anesthesiology; 1989 Oct; 71(4):561-4. PubMed ID: 2802213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of calcium channel blockers on the pharmacokinetics of propranolol stereoisomers.
    Hunt BA; Bottorff MB; Herring VL; Self TH; Lalonde RL
    Clin Pharmacol Ther; 1990 May; 47(5):584-91. PubMed ID: 2344707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.